GENI holder files Rule 144 notice to sell 162,737 common shares on NYSE (GENI)

Rhea-AI Filing Summary

A holder of common stock has filed notice of intent to sell 162,737 shares under Rule 144. The shares have an aggregate market value of $1,763,526.91 and are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of December 18, 2025.

All of these shares were acquired from the issuer as restricted stock vesting on multiple dates between January 3, 2023 and January 7, 2025 as compensation. The notice reports that 214,097,454 shares of this class were outstanding, providing context for the overall share count.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	162737	1763526.91	214097454	12/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/03/2023	Restricted Stock Vesting	Issuer			9805	01/03/2023	Compensation
Common	01/03/2024	Restricted Stock Vesting	Issuer			25450	01/03/2024	Compensation
Common	01/02/2025	Restricted Stock Vesting	Issuer			84213	01/02/2025	Compensation
Common	01/03/2025	Restricted Stock Vesting	Issuer			33086	01/03/2025	Compensation
Common	01/07/2025	Restricted Stock Vesting	Issuer			10183	01/07/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many GENI common shares are covered by this Rule 144 notice?

The notice covers 162,737 shares of common stock that are planned to be sold under Rule 144.

What is the aggregate market value of the GENI shares planned for sale?

The planned sale has an aggregate market value of $1,763,526.91 as reported in the notice.

When and where are the GENI shares expected to be sold?

The approximate date of sale is December 18, 2025, with the transaction to be executed on the NYSE through Fidelity Brokerage Services LLC.

How were the GENI shares being sold under Rule 144 originally acquired?

The shares were acquired from the issuer through restricted stock vesting as compensation on several dates: 9,805 shares on January 3, 2023, 25,450 shares on January 3, 2024, 84,213 shares on January 2, 2025, 33,086 shares on January 3, 2025, and 10,183 shares on January 7, 2025.

How many GENI shares of this class were outstanding according to the notice?

The notice states that there were 214,097,454 shares of this class outstanding.